India has been known to all biopharma companies as a destination to outsource R&D and manufacturing. However, the rapidly evolving landscape in India has opened doors beyond purely outsourcing for cost arbitrage. The seminar will present various elements of the evolving landscape to discuss the growing Indian opportunity for both young ventures and established companies.
The presentation will touch upon –
- Factors driving the expanded opportunity including renewed innovation focus in Indian companies,
- Availability of dilutive and non-dilutive funding for innovation advancement,
- Evolving disease profile and sustainable market growth opportunity driven by increasing disposable income and expanded access to healthcare,
The goal is to present models for young ventures to leverage strategic partnerships to expand and accelerate their commercialization programs. Opportunities for established companies across biopharma and medtech to expand their global footprint and participate in the growing market opportunity in India will be discussed along with case studies.
Pravin R. Chaturvedi, PH.D. Dr. Chaturvedi is a serial entrepreneur and a drug development veteran in the pharmaceutical and biotech community. He is the President & Chief Executive Officer of Boston- and Vancouver-based Pivot Pharmaceuticals, Inc., which recently acquired Boston-based IndUS Pharmaceuticals, which was founded and led by Dr. Chaturvedi until its acquisition. He is also the co-founder of Florida-based Oceanyx Pharmaceuticals. He remains an advisor to San Francisco-based Napo Pharmaceuticals, where he was the President and Chief Scientific Officer. Prior to his tenures at Pivot, IndUS, and Napo, he was the President and Chief Executive Officer of Boston-based Scion Pharmaceuticals, which was acquired by Wyeth (now Pfizer). Dr. Chaturvedi serves on the boards of Pivot, Oceanyx, Sindu Research Laboratories, Cellanyx, Bach Pharma, and two non-profit organizations, FuelEd Schools and PRADAN USA. He has previously served on the boards of Scion Pharmaceuticals, Sindu Pharmaceuticals and TiE Boston. He is an adjunct faculty member at Georgetown Medical School and serves on the advisory boards of several entities including Springboard Enterprises, a non-profit organization promoting women’s entrepreneurship. Over his 25+ year career, Dr. Chaturvedi has participated or led the discovery and/or the development activities for several new chemical entities (NCEs), culminating in the successful development and commercialization of several new drugs that are currently marketed by various companies. Prior to his entrepreneurial journey, Dr. Chaturvedi spent several years at Vertex Pharmaceuticals as the Head of Lead Evaluation and was in the preclinical group at Alkermes. He started his career in the Product Development group at Parke-Davis/Warner-Lambert Company (now Pfizer). Dr. Chaturvedi holds a Ph.D. in Pharmaceutical Sciences from West Virginia University and a Bachelor’s in Pharmacy from the University of Bombay.
Pushpa Vijayaraghavan, Vice President – Life Sciences Advisory, Sathguru Inc.
Pushpa leads the life sciences practice of Sathguru, a niche emerging markets focused strategy and innovation advisory firm. Founded in 1985 in India, Sathguru’s expertise includes South Asia focused corporate strategy, M&A and innovation advisory encompassing international innovation access, advancement and commercialization. Sathguru has a team of around 150 professionals across service offerings and has offices in India and USA.
Pushpa advises enterprises, research institutions and venture capitalists on advancing innovation and leveraging opportunities in India and other South Asian countries. Pushpa also leads engagements on market entry and growth strategy, research and product prioritization for emerging markets, strategic partnership opportunities, policy and M&A advisory. Pushpa’s prior experience of about thirteen years includes leading consulting engagements at PwC and Ernst &Young and a short stint in the University of Michigan Technology Transfer Office. She has a bachelor’s degree from Osmania University (India) and an MBA from the Ross School of Business at University of Michigan. Pushpa is an often called upon speaker on Indian and emerging market opportunity in life sciences, serves as an alumni advisor to the India Business Conference at the University of Michigan and has led policy advisory engagements for the World Bank and the Government of India among others.
Alka Shrikhande, Associate Vice President – Life Sciences Advisory, Sathguru Inc.
Alka Shrikhande is the lead resource in Sathguru’s healthcare practice in US. She advises global clients on innovation advancement opportunities and growth avenues in India and other emerging markets. She also works with several Indian companies on their efforts to access innovation and seek strategic partnerships with global partners.
Ms. Shrikhande is a life sciences professional with more than 20 years of experience in the US pharmaceutical industry. She started her career working on cardiovascular research at the Miles Institute of preclinical pharmacology which was later known as Bayer. At Bayer her work involved research in the area of osteoarthritis in the inflammation group advancing a kinase project into the clinics. She was a Senior Scientist in the neuroscience research unit at Pfizer in Groton, CT for over 12 years, contributing to numerous psychotherapeutic projects. In 2010, Alka started BioLink Consultants which offers strategic consulting and business development support to life science companies. Alka obtained her MSc specializing in Microbiology and MBA from the University of New Haven.